Purpose: To present a modified pharmacokinetic model for improved parameter accuracy and to investigate the influence of an inaccurate arterial input function (AIF) on dynamic contrast-enhanced (DCE)-MRI parameter estimates of the transfer constant (K trans ), blood volume (v p ), and interstitial volume (v e ).
Materials and Methods:Tissue uptake curves were simulated over a large range of physiological values and analyzed for different AIF measurement errors and temporal resolutions. The AIF measurement was assumed to be inaccurate in the bolus amplitude (rapid sampling) or susceptible to unknown temporal offsets (slow sampling with biexponential decay fit).
Results:The modified model adequately reduces errors in parameter estimates arising from transit time effects. An error in the AIF bolus amplitude results in an inversely proportional error in K trans and v p ; v e remains robust. More consistent error in K trans (Ϸ20% underestimation) was obtained using a biexponential AIF, at the expense of severely underestimating v p .
Conclusion:While an accurate, high temporal resolution AIF is essential for estimating v p , a biexponential AIF acquired at low temporal resolution (Ͻ20 seconds) provides robust estimates of v e and results in a K trans underestimation comparable to that from a 25% error in the initial AIF bolus amplitude. DYNAMIC CONTRAST-ENHANCED (DCE)-MRI for characterizing tissue uptake of a contrast agent is an established method for assessing microcirculation physiology. It is relevant in studying a wide range of diseases and conditions, including cancer (1), ischemia (2), and inflammation (3). Quantitative parameters directly related to underlying physiological properties, such as vessel permeability, perfusion, and blood volume, may be obtained by applying a pharmacokinetic model to the DCE-MRI data (4). This physiology-based information is beneficial in a number of ways, from improving cancer diagnostic sensitivity and specificity to elucidating microvascular changes that accompany novel anticancer therapies. However, the degree to which measured parameters represent true physiology is influenced by a number of factors, and accurate DCE-MRI quantification remains challenging (5).A problematic but necessary requirement for quantitative DCE-MRI is measurement of the arterial input function (AIF), or contrast agent concentration time course in the blood pool. The simplest approach is to use a standard AIF (6), but this may differ from the individual's input function, and large errors in pharmacokinetic parameter estimates have been reported (7). The ideal approach is to obtain individual measurements. This, however, is beset by a number of challenges. One challenge is achieving a high temporal resolution (1 second) to capture rapid changes during the initial bolus passage, which is believed to be essential for reliable DCE-MRI quantification (8). Despite the availability of faster scanners and parallel imaging, a lower temporal resolution is often used due to competing demands for high spatial res...